pittsburgh bpc 157 BPC-157 Injectable Peptide for Healing & Recovery BPC 157 | Gastric Pentadecapeptide

This peripheral inflammation is a known driver of neuroinflammation, which is implicated in mood disorders, cognitive decline, and neurodegenerative diseases

It is less obvious, however, why the hematocrit is unchanged

The American Journal of Psychiatry

Therefore, since the early 1990s, we have presented stable gastric pentadecapeptide BPC 157, and its pleiotropic beneficial effects, acting also via the per oral route [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40], as a late advantage of Robert and Szabos concept of cytoprotection [41,42,43,44,45,46,47,48,49]

Likewise, in addition to the mentioned Parkinsons disease models [198,199,200], these were induced by various central causes (e.g., spinal cord compression [170,230], stroke [145], traumatic brain injury [231], neurotoxin cuprizone that mimics multiple sclerosis in rats [232], neuroleptics [199,200], amphetamine [200,233], alcohol acute and chronic intoxication [234], serotonin syndrome [235], and NO-system blockade [200])